Why is Alpha-1-antitrypsin Low? Causes, Symptoms, and What to Do

Alpha-1-antitrypsin (AAT) is a protein produced by the liver that plays a crucial role in protecting the lungs from damage. When levels of this protein are low, it can lead to conditions like early-onset lung disease and liver problems. Understanding the causes and symptoms of low alpha-1-antitrypsin levels can help you take appropriate steps to manage your health.

What is Alpha-1-antitrypsin?

Alpha-1-antitrypsin is a protein made by the liver. Its main function is to protect the lungs from damage caused by enzymes that are released by inflammatory cells. Typically, alpha-1-antitrypsin levels in adults range from ~1.0–2.0 g/L. This protein acts as a protective barrier, preventing excessive tissue damage during inflammation.

Causes of Low Alpha-1-antitrypsin Levels

Low levels of alpha-1-antitrypsin, known as alpha-1-antitrypsin deficiency, can be caused by genetic factors. It is often inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations. Environmental factors such as smoking do not cause the deficiency, but smoking inactivates the AAT that is present and accelerates lung damage.

Symptoms of Low Alpha-1-antitrypsin Levels

Low levels of alpha-1-antitrypsin can lead to symptoms that primarily affect the lungs and liver. Individuals may experience shortness of breath, wheezing, and chronic cough, often leading to early-onset emphysema. Liver-related symptoms may include jaundice (yellowing of the skin and eyes), fatigue, and an enlarged liver. These symptoms can vary in severity depending on the level of deficiency.

Diagnosing Alpha-1-antitrypsin Deficiency

Diagnosis of alpha-1-antitrypsin deficiency typically involves a blood test to measure the level of the protein in the blood. If the levels are below the typical range of ~1.0–2.0 g/L, further genetic testing may be recommended to confirm the presence of mutations in the SERPINA1 gene, which is responsible for producing alpha-1-antitrypsin.

Treatment and Management

While there is no cure for alpha-1-antitrypsin deficiency, managing the condition involves lifestyle changes and medical interventions. Avoiding smoking and exposure to lung irritants is crucial. In some cases, individuals may receive augmentation therapy, which involves infusions of the alpha-1-antitrypsin protein to help protect the lungs. Regular monitoring and consultations with healthcare providers are important to manage symptoms effectively.

Frequently asked questions

What is considered a low level of alpha-1-antitrypsin? Low levels of alpha-1-antitrypsin are typically below the standard range of ~1.0–2.0 g/L. Levels below this range may indicate a deficiency.

Can lifestyle changes improve alpha-1-antitrypsin levels? While lifestyle changes cannot increase alpha-1-antitrypsin levels, avoiding smoking and reducing exposure to lung irritants can help manage symptoms and prevent further lung damage.

Is alpha-1-antitrypsin deficiency common? Alpha-1-antitrypsin deficiency is considered a rare genetic condition, though it may be underdiagnosed. Individuals with a family history of the condition are at higher risk.

How is alpha-1-antitrypsin deficiency treated? Treatment may include lifestyle changes, augmentation therapy, and regular monitoring by healthcare professionals to manage symptoms and prevent complications.

What are the long-term effects of low alpha-1-antitrypsin levels? Long-term effects can include chronic lung conditions like emphysema and liver diseases. Early diagnosis and management are key to reducing these risks.

When to see a doctor

If you experience symptoms such as unexplained shortness of breath, chronic cough, or jaundice, it is important to consult a healthcare provider. Additionally, if you have a family history of alpha-1-antitrypsin deficiency, you may want to discuss testing and monitoring options with your doctor.

Remember, this information is for educational purposes only. Always discuss your health decisions with your clinician.